Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Friday's Intraday Session

Author: Benzinga Insights | December 16, 2022 01:31pm

Gainers

  • Allarity Therapeutics (NASDAQ:ALLR) stock rose 164.2% to $0.7 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 17.6 million shares, making up 21425.0% of its average full-day volume over the last 100 days. The company's market cap stands at $7.2 million.
  • BeyondSpring (NASDAQ:BYSI) stock moved upwards by 52.28% to $2.33. Trading volume for this security as of 12:30 EST is 19.4 million, which is 9538.6% of its average full-day volume over the last 100 days. The company's market cap stands at $90.7 million.
  • Dermata Therapeutics (NASDAQ:DRMA) stock rose 44.93% to $0.28. The current volume of 16.4 million shares is 4223.4% of Dermata Therapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $3.4 million.
  • Ambrx Biopharma (NYSE:AMAM) shares moved upwards by 29.17% to $2.91. As of 12:30 EST, Ambrx Biopharma's stock is trading at a volume of 15.3 million, which is 545.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $112.2 million.
  • Rigel Pharmaceuticals (NASDAQ:RIGL) stock moved upwards by 20.53% to $1.53. Trading volume for this security as of 12:30 EST is 5.8 million, which is 147.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $264.5 million.
  • Gelesis Holdings (NYSE:GLS) stock moved upwards by 16.62% to $0.26. As of 12:30 EST, Gelesis Holdings's stock is trading at a volume of 421.3K, which is 273.0% of its average full-day volume over the last 100 days. The company's market cap stands at $19.0 million.

Losers

  • Synaptogenix (NASDAQ:SNPX) shares declined by 76.0% to $1.14 during Friday's regular session. Trading volume for this security as of 12:30 EST is 2.6 million, which is 4257.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $7.7 million.
  • BiondVax Pharmaceuticals (NASDAQ:BVXV) shares decreased by 55.75% to $3.85. As of 12:30 EST, this security is trading at a volume of 163.5K shares, making up 1477.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $7.2 million.
  • Scopus BioPharma (NASDAQ:SCPS) stock decreased by 46.4% to $0.18. Trading volume for Scopus BioPharma's stock is 2.7 million as of 12:30 EST. This is 320.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.8 million.
  • Guardant Health (NASDAQ:GH) shares fell 30.49% to $28.68. As of 12:30 EST, Guardant Health's stock is trading at a volume of 8.8 million, which is 845.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.9 billion.
  • Axcella Health (NASDAQ:AXLA) stock declined by 24.86% to $0.33. Trading volume for this security as of 12:30 EST is 333.7K, which is 168.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $24.2 million.
  • Seelos Therapeutics (NASDAQ:SEEL) shares fell 21.1% to $0.86. Seelos Therapeutics's stock is trading at a volume of 2.0 million shares as of 12:30 EST. This is 313.2% of its average full-day volume over the last 100 days. The company's market cap stands at $92.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ALLR AMAM AXLA BVXV BYSI DRMA GH GLS RIGL SCPS SEEL SNPX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist